- Series:Â Current Cancer Research
- Hardcover:Â 331 pages
- Publisher:Â Springer; 1st ed. 2018 edition (November 4, 2017)
- Language:Â English
Early Phase Cancer Immunotherapy (Current Cancer Research)Â 1st
byÂ
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
Â
Product details |